(Q33739301)

29 July 2017

1 reference

title

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. (English)

1 reference

29 July 2017

1 reference

1 reference

Holash J

1

1 reference

29 July 2017

Wiegand SJ

series ordinal

2

1 reference

29 July 2017

Yancopoulos GD

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

38

1 reference

29 July 2017

page(s)

5356-5362

1 reference

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Vascular endothelial growth factor: molecular and biological aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Angiopoietin-1 is an apoptosis survival factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203035

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203035

1 reference

Dimensions Publication ID

29 July 2017

1043078580

0 references

1 reference